PuSH - Publikationsserver des Helmholtz Zentrums München

Apisarnthanarax, S.* ; Bowen, S.R.* ; Combs, S.E.

Proton beam therapy and carbon ion radiotherapy for hepatocellular carcinoma.

Semin. Radiat. Oncol. 28, 309-320 (2018)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Charged particle therapy with proton beam therapy (PBT) and carbon ion radiotherapy (CIRT) has emerged as a promising radiation modality to minimize radiation hepatotoxicity while maintaining high rates of tumor local control. Both PBT and CIRT deposit the majority of their dose at the Bragg peak with little to no exit dose, resulting in superior sparing of normal liver tissue. CIRT has an additional biological advantage of increased relative biological effectiveness, which may allow for increased hypofractionation regimens. Retrospective and prospective studies have demonstrated encouragingly high rates of local control and overall survival and low rates of hepatotoxicity with PBT and CIRT. Ongoing randomized trials will evaluate the value of PBT over photons and other standard liver-directed therapies and future randomized trials are needed to assess the value of CIRT over PBT.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Korrespondenzautor
Schlagwörter Stereotactic Body Radiotherapy; Effectiveness Rbe Values; Radiation-therapy; Phase-ii; Transarterial Chemoembolization; Liver Toxicity; Porta-hepatis; Irradiation; Cirrhosis; Model
ISSN (print) / ISBN 1053-4296
e-ISSN 1532-9461
Zeitschrift Seminars in Radiation Oncology
Quellenangaben Band: 28, Heft: 4, Seiten: 309-320 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort 1600 John F Kennedy Boulevard, Ste 1800, Philadelphia, Pa 19103-2899 Usa
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Radiation Medicine (IRM)